| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Medical Genetics, Haartman Institute and Helsinki University Central Hospital, University of Helsinki, Finland; 2 St. Erik’s Eye Hospital, Stockholm, Sweden; and 3 Molecular and Cellular Tumor Pathology, Department of Oncology and Pathology, Karolinska Hospital, Stockholm, Sweden.
PURPOSE. To elucidate the genetic differences between metastasizing and nonmetastasizing primary tumors, uveal melanoma samples were screened for DNA copy number alterations by comparative genomic hybridization (CGH).
METHODS. DNA copy number changes were studied on 14 primary uveal melanomas that had not metastasized, 15 primary uveal melanomas that had metastasized, and on 6 metastases that were available from 6 primary uveal melanomas. CGH is based on quantitation of the fluorescence intensity of differentially labeled DNAs. Tumor DNA labeled with FITC dCTP and dUTP and normal DNA labeled with Texas red dCTP and dUTP were hybridized to normal metaphase chromosomes. The hybridizations were analyzed using an Olympus fluorescence microscope and the ISIS digital image analysis system to identify gain or loss of genetic material.
RESULTS. Primary uveal melanomas that had metastasized and metastases had significantly more changes than primary uveal melanomas that had not metastasized. Comparison between primary nonmetastasizing tumors, metastasizing tumors, and metastases showed that the most common DNA copy number changes were -3 (21%, 73%, 67%, respectively), -6q (7%, 40%, 83%), -1p (0, 33%, 33%), -13q (14%, 13%, 50%), -8p (14%, 27%, 0), -18 (7%, 13%, 33%), +8q (14%, 53%, 100%), +6p (29%, 20%, 17%), +1q (0, 7%, 33%), and +16p (0, 7%, 33%).
CONCLUSIONS. Loss of chromosome 3, loss of 6q, and gain of 8q were significantly associated with poor overall survival. In addition, losses of 1p were only found in primary uveal melanomas that had metastasized and in metastases, which suggests that this region may harbor a tumor suppressor gene important in the tumor progression. Finally, loss of chromosome 3 may be associated with isochromosome formation of 1q, 6p, 8q, 16p, 20q, and 22q.
This article has been cited by other articles:
|
|
 |
|
  M. D. Onken, L. A. Worley, and J. W. Harbour A Metastasis Modifier Locus on Human Chromosome 8p in Uveal Melanoma Identified by Integrative Genomic Analysis Clin. Cancer Res., June 15, 2008; 14(12): 3737 - 3745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Ehlers, L. Worley, M. D. Onken, and J. W. Harbour Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma Clin. Cancer Res., January 1, 2008; 14(1): 115 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. van Gils, H. W. Mensink, E. Kilic, J. Vaarwater, M. M. Verbiest, D. Paridaens, G. P. Luyten, A. de Klein, and H. T. Bruggenwirth Expression of APITD1 Is Not Related to Copy Number Changes of Chromosomal Region 1p36 or the Prognosis of Uveal Melanoma Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4919 - 4923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C Santos, M Zielenska, M Prasad, and J A Squire Chromosome 6p amplification and cancer progression J. Clin. Pathol., January 1, 2007; 60(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sandinha, M. Farquharson, I. McKay, and F. Roberts Correlation of Heterogeneity for Chromosome 3 Copy Number with Cell Type in Choroidal Melanoma of Mixed-Cell Type Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5177 - 5180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kilic, W. van Gils, E. Lodder, H. B. Beverloo, M. E. van Til, C. M. Mooy, D. Paridaens, A. de Klein, and G. P. M. Luyten Clinical and cytogenetic analyses in uveal melanoma. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3703 - 3707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Sandinha, M. A. Farquharson, I. C. McKay, and F. Roberts Monosomy 3 Predicts Death but Not Time until Death in Choroidal Melanoma Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3497 - 3501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kilic, N. C. Naus, W. van Gils, C. C. Klaver, M. E. van Til, M. M. Verbiest, T. Stijnen, C. M. Mooy, D. Paridaens, H. B. Beverloo, et al. Concurrent Loss of Chromosome Arm 1p and Chromosome 3 Predicts a Decreased Disease-Free Survival in Uveal Melanoma Patients Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2253 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Abdel-Rahman, E. L. Craig, F. H. Davidorf, and C. Eng Expression of Vascular Endothelial Growth Factor in Uveal Melanoma Is Independent of 6p21-Region Copy Number Clin. Cancer Res., January 1, 2005; 11(1): 73 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M T Sandinha, M A Farquharson, and F Roberts Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation Br. J. Ophthalmol., December 1, 2004; 88(12): 1527 - 1532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Onken, L. A. Worley, J. P. Ehlers, and J. W. Harbour Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death Cancer Res., October 15, 2004; 64(20): 7205 - 7209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Hurst, J. W. Harbour, and L. A. Cornelius Ocular Melanoma: A Review and the Relationship to Cutaneous Melanoma Arch Dermatol, August 1, 2003; 139(8): 1067 - 1073. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
